United States - English - NLM (National Library of Medicine)

mwi - gentamicin sulfate (unii: 8x7386qrlv) (gentamicin - unii:t6z9v48ikg), betamethasone valerate (unii: 9ifa5xm7r2) (betamethasone - unii:9842x06q6m) - gentamicin 3 mg in 1 ml - indications: gentamicin sulfate with betamethasone valerate otic solution is indicated for the treatment of acute and chronic canine otitis externa and canine and feline superficial infected lesions caused by bacteria sensitive to gentamicin. contraindications: if hypersensitivity of any of the components occurs, treatment with this product should be discontinued and appropriate therapy instituted. concomitant use of drugs known to induce ototoxicity should be avoided. this preparation should not be used in conditions where corticosteroids are contraindicated. do not administer parenteral corticosteroids during treatment with gentamicin sulfate with betamethasone valerate otic solution.

United States - English - NLM (National Library of Medicine)

clipper distributing company llc - gentamicin sulfate (unii: 8x7386qrlv) (gentamicin - unii:t6z9v48ikg), betamethasone valerate (unii: 9ifa5xm7r2) (betamethasone - unii:9842x06q6m) - gentamicin 3 mg in 1 ml - indications: gentamicin sulfate with betamethasone valerate otic solution is indicated for the treatment of acute and chronic canine otitis externa and canine and feline superficial infected lesions caused by bacteria sensitive to gentamicin. contraindications: if hypersensitivity of any of the components occurs, treatment with this product should be discontinued and appropriate therapy instituted. concomitant use of drugs known to induce ototoxicity should be avoided. this preparation should not be used in conditions where corticosteroids are contraindicated. do not administer parenteral corticosteroids during treatment with gentamicin sulfate with betamethasone valerate otic solution.

United States - English - NLM (National Library of Medicine)

henry schein animal health - gentamicin sulfate (unii: 8x7386qrlv) (gentamicin - unii:t6z9v48ikg), betamethasone valerate (unii: 9ifa5xm7r2) (betamethasone - unii:9842x06q6m) - gentamicin 3 mg in 1 ml - indications: gentamicin sulfate with betamethasone valerate otic solution is indicated for the treatment of acute and chronic canine otitis externa and canine and feline superficial infected lesions caused by bacteria sensitive to gentamicin. contraindications: if hypersensitivity of any of the components occurs, treatment with this product should be discontinued and appropriate therapy instituted. concomitant use of drugs known to induce ototoxicity should be avoided. this preparation should not be used in conditions where corticosteroids are contraindicated. do not administer parenteral corticosteroids during treatment with gentamicin sulfate with betamethasone valerate otic solution.

United States - English - NLM (National Library of Medicine)

covetrus north america - gentamicin sulfate (unii: 8x7386qrlv) (gentamicin - unii:t6z9v48ikg), betamethasone valerate (unii: 9ifa5xm7r2) (betamethasone - unii:9842x06q6m) - indications: gentamicin sulfate with betamethasone valerate otic solution is indicated for the treatment of acute and chronic canine otitis externa and canine and feline superficial infected lesions caused by bacteria sensitive to gentamicin. contraindications: if hypersensitivity of any of the components occurs, treatment with this product should be discontinued and appropriate therapy instituted. concomitant use of drugs known to induce ototoxicity should be avoided. this preparation should not be used in conditions where corticosteroids are contraindicated. do not administer parenteral corticosteroids during treatment with gentamicin sulfate with betamethasone valerate otic solution.

United States - English - NLM (National Library of Medicine)

rebel distributors corp. - betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

United States - English - NLM (National Library of Medicine)

unit dose services - clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65), betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - clotrimazole and betamethasone dipropionate cream, 1%/0.05% (base) is a combination of an azole antifungal and corticosteroid and is indicated for the topical treatment of symptomatic inflammatory tinea pedis, tinea cruris, and tinea corporis due to epidermophyton floccosum , trichophyton mentagrophytes , and trichophyton rubrum in patients 17 years and older. none. teratogenic effects, pregnancy category c there are no adequate and well-controlled studies with clotrimazole and betamethasone dipropionate cream, 1%/0.05% (base) in pregnant women. therefore, clotrimazole and betamethasone dipropionate cream, 1%/0.05% (base) should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. there have been no teratogenic studies performed in animals or humans with the combination of clotrimazole and betamethasone dipropionate. corticosteroids are generally teratogenic in laboratory animals when administered at relatively low dosage levels. studies in pregnant rats with intr

United States - English - NLM (National Library of Medicine)

unit dose services - clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65), betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - clotrimazole and betamethasone dipropionate cream, 1%/0.05% (base) is a combination of an azole antifungal and corticosteroid and is indicated for the topical treatment of symptomatic inflammatory tinea pedis, tinea cruris, and tinea corporis due to epidermophyton floccosum , trichophyton mentagrophytes , and trichophyton rubrum in patients 17 years and older. none. teratogenic effects, pregnancy category c there are no adequate and well-controlled studies with clotrimazole and betamethasone dipropionate cream, 1%/0.05% (base) in pregnant women. therefore, clotrimazole and betamethasone dipropionate cream, 1%/0.05% (base) should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. there have been no teratogenic studies performed in animals or humans with the combination of clotrimazole and betamethasone dipropionate. corticosteroids are generally teratogenic in laboratory animals when administered at relatively low dosage levels. studies in pregnant rats with intr

United States - English - NLM (National Library of Medicine)

a-s medication solutions - betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - betamethasone dipropionate cream is a medium-potency corticosteroid indicated for relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 13 years and older. betamethasone dipropionate cream is contraindicated in patients who are hypersensitive to betamethasone dipropionate, to other corticosteroids, or to any ingredient in this preparation.

United States - English - NLM (National Library of Medicine)

a-s medication solutions - clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65), betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - clotrimazole and betamethasone dipropionate cream usp is a combination of an azole antifungal and corticosteroid and is indicated for the topical treatment of symptomatic inflammatory tinea pedis, tinea cruris, and tinea corporis due to epidermophyton floccosum, trichophyton mentagrophytes, and trichophyton rubrum in patients 17 years and older. none. teratogenic effects, pregnancy category c there are no adequate and well-controlled studies with clotrimazole and betamethasone dipropionate cream in pregnant women. therefore, clotrimazole and betamethasone dipropionate cream should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. there have been no teratogenic studies performed in animals or humans with the combination of clotrimazole and betamethasone dipropionate. corticosteroids are generally teratogenic in laboratory animals when administered at relatively low dosage levels. studies in pregnant rats with intravaginal doses up to 100 mg/kg (15 times th

United States - English - NLM (National Library of Medicine)

a-s medication solutions - clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65), betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - clotrimazole and betamethasone dipropionate cream usp is a combination of an azole antifungal and corticosteroid and is indicated for the topical treatment of symptomatic inflammatory tinea pedis, tinea cruris, and tinea corporis due to epidermophyton floccosum, trichophyton mentagrophytes, and trichophyton rubrum in patients 17 years and older. none. teratogenic effects, pregnancy category c there are no adequate and well-controlled studies with clotrimazole and betamethasone dipropionate cream in pregnant women. therefore, clotrimazole and betamethasone dipropionate cream should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. there have been no teratogenic studies performed in animals or humans with the combination of clotrimazole and betamethasone dipropionate. corticosteroids are generally teratogenic in laboratory animals when administered at relatively low dosage levels. studies in pregnant rats with intravaginal doses up to 100 mg/kg (15 times th